Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000139 | Golgi membrane | 5 | 2 |
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0005794 | Golgi apparatus | 5 | 2 |
GO:0012505 | endomembrane system | 2 | 2 |
GO:0016020 | membrane | 2 | 12 |
GO:0031090 | organelle membrane | 3 | 2 |
GO:0031201 | SNARE complex | 3 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0098588 | bounding membrane of organelle | 4 | 2 |
GO:0098796 | membrane protein complex | 2 | 2 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 12 |
Related structures:
AlphaFold database: Q4Q5S9
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 12 |
GO:0006886 | intracellular protein transport | 4 | 2 |
GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 4 | 2 |
GO:0006906 | vesicle fusion | 6 | 2 |
GO:0006996 | organelle organization | 4 | 2 |
GO:0008104 | protein localization | 4 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0015031 | protein transport | 4 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0016050 | vesicle organization | 5 | 2 |
GO:0016192 | vesicle-mediated transport | 4 | 12 |
GO:0022406 | membrane docking | 2 | 2 |
GO:0033036 | macromolecule localization | 2 | 2 |
GO:0045184 | establishment of protein localization | 3 | 2 |
GO:0046907 | intracellular transport | 3 | 2 |
GO:0048193 | Golgi vesicle transport | 5 | 2 |
GO:0048278 | vesicle docking | 4 | 2 |
GO:0048284 | organelle fusion | 5 | 2 |
GO:0051179 | localization | 1 | 12 |
GO:0051234 | establishment of localization | 2 | 12 |
GO:0051640 | organelle localization | 2 | 2 |
GO:0051641 | cellular localization | 2 | 2 |
GO:0051649 | establishment of localization in cell | 3 | 2 |
GO:0061024 | membrane organization | 4 | 2 |
GO:0061025 | membrane fusion | 5 | 2 |
GO:0070727 | cellular macromolecule localization | 3 | 2 |
GO:0071702 | organic substance transport | 4 | 2 |
GO:0071705 | nitrogen compound transport | 4 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
GO:0090174 | organelle membrane fusion | 6 | 2 |
GO:0140056 | organelle localization by membrane tethering | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000149 | SNARE binding | 3 | 2 |
GO:0005484 | SNAP receptor activity | 3 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0005515 | protein binding | 2 | 2 |
GO:0030674 | protein-macromolecule adaptor activity | 2 | 2 |
GO:0060090 | molecular adaptor activity | 1 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.402 |
CLV_NRD_NRD_1 | 46 | 48 | PF00675 | 0.469 |
CLV_PCSK_KEX2_1 | 115 | 117 | PF00082 | 0.396 |
CLV_PCSK_KEX2_1 | 45 | 47 | PF00082 | 0.435 |
CLV_PCSK_PC1ET2_1 | 45 | 47 | PF00082 | 0.435 |
CLV_PCSK_SKI1_1 | 107 | 111 | PF00082 | 0.381 |
CLV_PCSK_SKI1_1 | 116 | 120 | PF00082 | 0.416 |
CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.330 |
CLV_PCSK_SKI1_1 | 63 | 67 | PF00082 | 0.540 |
CLV_Separin_Metazoa | 210 | 214 | PF03568 | 0.435 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.712 |
DOC_PIKK_1 | 36 | 44 | PF02985 | 0.647 |
DOC_USP7_MATH_1 | 48 | 52 | PF00917 | 0.652 |
LIG_14-3-3_CanoR_1 | 116 | 125 | PF00244 | 0.563 |
LIG_14-3-3_CanoR_1 | 99 | 103 | PF00244 | 0.579 |
LIG_Actin_WH2_2 | 95 | 112 | PF00022 | 0.564 |
LIG_BIR_III_4 | 61 | 65 | PF00653 | 0.685 |
LIG_BRCT_BRCA1_1 | 129 | 133 | PF00533 | 0.628 |
LIG_FHA_1 | 15 | 21 | PF00498 | 0.589 |
LIG_FHA_1 | 178 | 184 | PF00498 | 0.580 |
LIG_FHA_1 | 22 | 28 | PF00498 | 0.528 |
LIG_FHA_2 | 118 | 124 | PF00498 | 0.626 |
LIG_FHA_2 | 193 | 199 | PF00498 | 0.463 |
LIG_FHA_2 | 38 | 44 | PF00498 | 0.577 |
LIG_FHA_2 | 80 | 86 | PF00498 | 0.572 |
LIG_GBD_Chelix_1 | 83 | 91 | PF00786 | 0.357 |
LIG_LIR_Gen_1 | 174 | 183 | PF02991 | 0.540 |
LIG_LIR_LC3C_4 | 241 | 244 | PF02991 | 0.171 |
LIG_LIR_Nem_3 | 174 | 179 | PF02991 | 0.534 |
LIG_Pex14_2 | 229 | 233 | PF04695 | 0.303 |
LIG_Pex14_2 | 235 | 239 | PF04695 | 0.303 |
LIG_PTB_Apo_2 | 148 | 155 | PF02174 | 0.614 |
LIG_PTB_Phospho_1 | 148 | 154 | PF10480 | 0.617 |
LIG_SH2_STAT3 | 154 | 157 | PF00017 | 0.563 |
LIG_SH2_STAT5 | 214 | 217 | PF00017 | 0.442 |
LIG_SUMO_SIM_par_1 | 160 | 166 | PF11976 | 0.595 |
LIG_TRAF2_1 | 168 | 171 | PF00917 | 0.613 |
LIG_TRAF2_1 | 40 | 43 | PF00917 | 0.583 |
MOD_CK1_1 | 21 | 27 | PF00069 | 0.593 |
MOD_CK2_1 | 37 | 43 | PF00069 | 0.576 |
MOD_CK2_1 | 79 | 85 | PF00069 | 0.592 |
MOD_GlcNHglycan | 129 | 132 | PF01048 | 0.425 |
MOD_GlcNHglycan | 146 | 149 | PF01048 | 0.377 |
MOD_GSK3_1 | 105 | 112 | PF00069 | 0.560 |
MOD_GSK3_1 | 14 | 21 | PF00069 | 0.614 |
MOD_GSK3_1 | 192 | 199 | PF00069 | 0.460 |
MOD_GSK3_1 | 213 | 220 | PF00069 | 0.538 |
MOD_GSK3_1 | 48 | 55 | PF00069 | 0.580 |
MOD_GSK3_1 | 73 | 80 | PF00069 | 0.610 |
MOD_N-GLC_1 | 216 | 221 | PF02516 | 0.263 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.597 |
MOD_NEK2_1 | 109 | 114 | PF00069 | 0.580 |
MOD_NEK2_1 | 144 | 149 | PF00069 | 0.646 |
MOD_NEK2_1 | 238 | 243 | PF00069 | 0.171 |
MOD_NEK2_1 | 26 | 31 | PF00069 | 0.645 |
MOD_NEK2_1 | 65 | 70 | PF00069 | 0.693 |
MOD_NEK2_1 | 91 | 96 | PF00069 | 0.573 |
MOD_NEK2_1 | 98 | 103 | PF00069 | 0.560 |
MOD_PIKK_1 | 1 | 7 | PF00454 | 0.591 |
MOD_PIKK_1 | 149 | 155 | PF00454 | 0.641 |
MOD_PIKK_1 | 21 | 27 | PF00454 | 0.627 |
MOD_PIKK_1 | 48 | 54 | PF00454 | 0.662 |
MOD_PKA_2 | 1 | 7 | PF00069 | 0.611 |
MOD_PKA_2 | 73 | 79 | PF00069 | 0.607 |
MOD_PKA_2 | 98 | 104 | PF00069 | 0.575 |
MOD_Plk_1 | 177 | 183 | PF00069 | 0.565 |
MOD_Plk_1 | 21 | 27 | PF00069 | 0.618 |
MOD_Plk_2-3 | 37 | 43 | PF00069 | 0.578 |
MOD_Plk_4 | 238 | 244 | PF00069 | 0.171 |
MOD_Plk_4 | 79 | 85 | PF00069 | 0.597 |
MOD_Plk_4 | 8 | 14 | PF00069 | 0.639 |
TRG_ER_diArg_1 | 87 | 90 | PF00400 | 0.590 |
TRG_NLS_MonoExtC_3 | 44 | 50 | PF00514 | 0.669 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IME4 | Leptomonas seymouri | 85% | 82% |
A0A0S4JCP0 | Bodo saltans | 58% | 78% |
A0A1X0P6P0 | Trypanosomatidae | 68% | 75% |
A0A3R7KH07 | Trypanosoma rangeli | 65% | 74% |
A0A3S7X532 | Leishmania donovani | 94% | 100% |
A4HJY7 | Leishmania braziliensis | 91% | 100% |
A4I7H0 | Leishmania infantum | 94% | 100% |
C9ZZZ8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 61% | 75% |
E9B2C7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
O13644 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 27% | 79% |
Q01590 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 26% | 72% |
Q08851 | Rattus norvegicus | 30% | 69% |
Q08DB5 | Bos taurus | 30% | 69% |
Q13190 | Homo sapiens | 30% | 69% |
Q8K1E0 | Mus musculus | 31% | 69% |
Q9FFK1 | Arabidopsis thaliana | 24% | 73% |
Q9LK09 | Arabidopsis thaliana | 26% | 71% |
V5BWT4 | Trypanosoma cruzi | 66% | 74% |